FI67686C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenetanolaminderivat - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenetanolaminderivat Download PDF

Info

Publication number
FI67686C
FI67686C FI792080A FI792080A FI67686C FI 67686 C FI67686 C FI 67686C FI 792080 A FI792080 A FI 792080A FI 792080 A FI792080 A FI 792080A FI 67686 C FI67686 C FI 67686C
Authority
FI
Finland
Prior art keywords
formula
dimethyl
compound
phenyl
tumor
Prior art date
Application number
FI792080A
Other languages
English (en)
Finnish (fi)
Other versions
FI792080A (fi
FI67686B (fi
Inventor
Jack Mills
Klaus Kurt Schmiegel
Richard Eugene Toomey
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI792080A publication Critical patent/FI792080A/fi
Publication of FI67686B publication Critical patent/FI67686B/fi
Application granted granted Critical
Publication of FI67686C publication Critical patent/FI67686C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI792080A 1978-07-03 1979-07-02 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenetanolaminderivat FI67686C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92166878A 1978-07-03 1978-07-03
US92166878 1978-07-03

Publications (3)

Publication Number Publication Date
FI792080A FI792080A (fi) 1980-01-04
FI67686B FI67686B (fi) 1985-01-31
FI67686C true FI67686C (fi) 1985-05-10

Family

ID=25445786

Family Applications (1)

Application Number Title Priority Date Filing Date
FI792080A FI67686C (fi) 1978-07-03 1979-07-02 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenetanolaminderivat

Country Status (33)

Country Link
EP (2) EP0047536B1 (de)
JP (1) JPS559100A (de)
AR (2) AR222658A1 (de)
AT (1) AT370408B (de)
AU (1) AU521744B2 (de)
BE (1) BE877392A (de)
BG (3) BG40482A3 (de)
CA (1) CA1120058A (de)
CH (1) CH641759A5 (de)
CS (2) CS208660B2 (de)
DD (1) DD144763A5 (de)
DK (1) DK268579A (de)
EG (1) EG14400A (de)
ES (2) ES482153A1 (de)
FI (1) FI67686C (de)
FR (1) FR2430409A1 (de)
GB (1) GB2028800B (de)
GR (1) GR72546B (de)
HK (1) HK44087A (de)
HU (1) HU179170B (de)
IE (1) IE48436B1 (de)
IL (1) IL57670A (de)
LU (1) LU81456A1 (de)
MX (1) MX6160E (de)
MY (1) MY8500596A (de)
NZ (1) NZ190859A (de)
PH (1) PH15650A (de)
PL (2) PL123990B1 (de)
PT (1) PT69840A (de)
RO (2) RO83053B (de)
SU (2) SU965351A3 (de)
YU (1) YU154879A (de)
ZA (1) ZA793295B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965655D1 (en) * 1978-06-28 1983-07-21 Beecham Group Plc Secondary amines, their preparation, pharmaceutical compositions containing them and their use
NL8105170A (nl) * 1980-12-10 1982-07-01 Thomae Gmbh Dr K Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen.
EP0068669A1 (de) * 1981-06-20 1983-01-05 Beecham Group Plc Sekundäre Phenyläthanolamine, Verfahren zu deren Herstellung und deren pharmazeutische Verwendung
CA1219865A (en) * 1982-05-14 1987-03-31 Leo Alig Aziridine phenethanolamine derivatives
CA1258454A (en) * 1982-08-10 1989-08-15 Leo Alig Phenethanolamines
EP0102213A1 (de) * 1982-08-21 1984-03-07 Beecham Group Plc Ethanolaminderivate, sie enthaltende pharmazeutische Mittel sowie Verfahren zu ihrer Herstellung
DE3473439D1 (en) * 1983-01-31 1988-09-22 Lilly Co Eli Improvements in or relating to phenethanolamines
US4849453A (en) * 1983-01-31 1989-07-18 Eli Lilly And Company Growth promotion
US4569801A (en) * 1984-10-15 1986-02-11 Eli Lilly And Company Alkylsulfonamidophenylalkylamines
JPS62155213A (ja) * 1985-12-20 1987-07-10 イ−ライ・リリ−・アンド・カンパニ− 腫瘍細胞崩壊剤
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
US5135955A (en) * 1988-04-25 1992-08-04 Eli Lilly And Company Propanamine derivatives
US5051423A (en) * 1988-07-13 1991-09-24 Schering Ag Derivatized alkanolamines as cardiovascular agents
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
CN1073983C (zh) * 1994-10-31 2001-10-31 中国科学院成都有机化学研究所 一种β－拟肾上腺素兴奋剂型饲料添加剂的合成方法
JP4448902B2 (ja) 2001-06-08 2010-04-14 株式会社医薬分子設計研究所 スルホンアミド誘導体
TW200740779A (en) 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6610530A (de) * 1966-07-27 1968-01-29
BE757005A (fr) * 1969-10-02 1971-04-02 Bristol Myers Co Phenethanolamines substituees et procede pour leur preparation
US3801631A (en) * 1972-02-16 1974-04-02 Mead Johnson & Co 2'-hydroxy-5'-(1-hydroxy-2-(2-methyl-1-phenyl-2-propylamino)ethyl)meth-anesulfonanilide and its salts

Also Published As

Publication number Publication date
ATA463979A (de) 1982-08-15
DK268579A (da) 1980-01-04
BG40482A3 (en) 1986-12-15
MY8500596A (en) 1985-12-31
AU521744B2 (en) 1982-04-29
EP0047536A3 (en) 1982-03-24
IE48436B1 (en) 1985-01-23
FR2430409A1 (fr) 1980-02-01
CA1120058A (en) 1982-03-16
SU965351A3 (ru) 1982-10-07
PH15650A (en) 1983-03-11
LU81456A1 (fr) 1979-10-30
EG14400A (en) 1983-12-31
DD144763A5 (de) 1980-11-05
JPS636058B2 (de) 1988-02-08
YU154879A (en) 1983-04-30
IL57670A0 (en) 1979-10-31
BE877392A (fr) 1980-01-02
PL222867A1 (de) 1981-01-02
AU4848879A (en) 1980-01-10
EP0007206A1 (de) 1980-01-23
FI792080A (fi) 1980-01-04
ES8101537A1 (es) 1980-12-16
MX6160E (es) 1984-11-29
RO83053B (ro) 1984-02-28
GB2028800B (en) 1982-11-03
FI67686B (fi) 1985-01-31
GB2028800A (en) 1980-03-12
GR72546B (de) 1983-11-17
AR222727A1 (es) 1981-06-15
CS208661B2 (en) 1981-09-15
AT370408B (de) 1983-03-25
ES482153A1 (es) 1980-08-16
CS208660B2 (en) 1981-09-15
NZ190859A (en) 1984-09-28
BG40480A3 (en) 1986-12-15
IE791231L (en) 1980-01-03
ES487847A0 (es) 1980-12-16
CH641759A5 (fr) 1984-03-15
PL216810A1 (de) 1980-07-28
FR2430409B1 (de) 1981-05-29
JPS559100A (en) 1980-01-22
EP0007206B1 (de) 1983-02-23
RO83053A (ro) 1984-02-21
ZA793295B (en) 1981-02-25
EP0047536B1 (de) 1984-06-27
RO77731A (ro) 1981-11-24
PL119783B1 (en) 1982-01-30
HU179170B (en) 1982-08-28
EP0047536A2 (de) 1982-03-17
SU931102A3 (ru) 1982-05-23
BG40481A3 (en) 1986-12-15
AR222658A1 (es) 1981-06-15
PL123990B1 (en) 1982-12-31
PT69840A (en) 1979-07-01
HK44087A (en) 1987-06-12
IL57670A (en) 1982-11-30

Similar Documents

Publication Publication Date Title
FI67686C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fenetanolaminderivat
JP2656699B2 (ja) 置換ベンジルアミノキヌクリジン
JP4685243B2 (ja) ピリミド［６，１−ａ］イソキノリン−４−オン誘導体
JP2003515590A (ja) 癌を処置するためのクルクミンアナログ
US7759361B2 (en) Azabicyclooctan-3-one derivatives and use thereof
AU648121B2 (en) Synergism of HIV reverse transcriptase inhibitors
NZ212856A (en) Glutarimide derivatives and pharmaceutical compositions
WO1994009001A1 (en) Pyrroloquinoline bradykinin antagonist
JPH07503703A (ja) （−）−エゼロリン、（−）−ｎ１−ノルエゼロリンおよび（−）−ｎ１−ベンジルノルエゼロリンの置換フェンゼリンおよびフェニルカルバミン酸塩：特異的アセチルコリンエステラーゼ阻害薬としての使用
JPS62111962A (ja) ３−フエニルチオメチルスチレン誘導体
US6387389B1 (en) Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use
US4942163A (en) 1(2H)-isoquinolinones and 1-isoquinolineamines as cancer chemotherapeutic agents
JPH11506453A (ja) 水溶性カンプトテシン類似体
CA2196370A1 (en) Isoprene derivatives
JPH0755923B2 (ja) 医薬組成物
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
Kam et al. [(Arylcarbonyl) oxy] propanolamines. 1. Novel. beta.-blockers with ultrashort duration of action
US20020037931A1 (en) Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
US4528299A (en) 1-(2,3-Dimethyl-4-methoxyphenyl)-2-methyl-3-(1-pyrrolidinyl)-1-propanone and anti-spastic use thereof
EP4310070A1 (de) Verwendung von transamantadinderivaten oder deren salzen
TWI254707B (en) Benzazepine derivatives as MAO-B inhibitors
GB1590155A (en) Cis-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindines and pharmaceutical compositions containing them
AU774981B2 (en) Thiazolopyrimidines useful as TNFalpha inhibitors
US3457354A (en) Treatment of hypertension with 2-hydroxy (or amino) - 4,5 - dihydroxyphenethylamine derivatives
FI67364B (fi) Foerfarande foer framstaellning av en ny farmakologiskt aktiv 1-fenyl-2-(fenoxi-isopropylamino)-1,3-propandiol

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ELI LILLY AND COMPANY